 |
FDA Approval Activities for this Drug
Orfadin (Nitisinone) Capsules, Swedish Orphan, (R&R Registration is the U.S. Agent NDA 21-232 1/18/02 2/5/02 2/5/02 2/28/02
Orfadin Indications: An adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia tyep 1. | Orfadin (nitisinone) Capsules, R & R Registrations, Labeling Revision
View updates.
|